Alcohol and AFA-281 interaction study in healthy volunteers
Treatments studied
Part of Mental health clinical trials.
This study tests how alcohol interacts with a new drug called AFA-281 in healthy adults. You may qualify if you regularly drink alcohol but do not have alcohol use disorder.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 21 and 55 years old.
- You regularly drink alcohol (7–21 drinks per week for the past 6 months) but do not have alcohol use disorder.
- You have a body mass index (BMI) between 18.5 and 30.
- You are in good health, with no major medical conditions like heart disease, epilepsy, or liver disease.
- You do not smoke or use nicotine, are willing to avoid strenuous exercise, and will use birth control if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental medication called AFA-281 to see if it's safe and could help reduce heavy drinking in people with moderate to severe alcohol use disorder. You must drink a high number of drinks per week to qualify.
This Phase 1 study looks at sex differences in how the body and brain respond when people stop drinking alcohol for a short time. You may be asked to complete questionnaires and provide blood samples to measure changes during the abstinence period.
This early-phase study looks at how the brain’s opioid receptor balance may be different in people with alcohol use disorder (AUD), using brain scans and blood testing. It may help researchers understand why some people respond differently to alcohol and related treatments.
This study uses a brain-and-behavior “assessment” (neuroclinical testing) to better understand addiction. You may be tested only if you are an adult and are enrolled in the NIAAA screening program, and you cannot join if you are acutely intoxicated.
This study tests whether avoiding alcohol completely for two weeks helps people with AFib have fewer episodes, compared to allowing regulated drinking. You will be randomly assigned to one of the two groups.
This trial tests how the medication acamprosate affects brain activity in people with moderate to severe alcohol use disorder. It may help researchers understand how this treatment works.
Hear when a new Alcohol trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.